FOM has resolved to realize the following objectives within the following years

• Development and research in the field orthomolecular medicine
• Support of innovative medical paths with emphasis on prevention: impartment of integral-traditional-medicine-oriented primary, secondary and tertiary preventive medicine
• Information und training of health care professionals and laymen
• Exchange of experiences

Projects of FOM

For Professions in Health Care and Science

• Standardized advanced training with curriculum and diploma
• Organisation und support of advanced training events
• Reduced training fees for members
• Regular info services for members, sponsoring members and interested people
• Literature Service
• Exchange of experience and cooperation with interested partner associations
• Support and organisation of studies on the practical use of orthomolecular medicine
• Support of judicial and natural persons who engage in the objectives of FOM
• Development of scientific standards for research, diagnostics, prevention and therapy
• Publication of scientific and practical experiences

For The Public

• Education, information and training in orthomolecular medicine (physician-patient seminars, print material, hotline, internet)

Observation of long-term practical use of orthomolecular medicine

The demand for orthomolecular medicine has increased worldwide in the recent years. On the one hand, this is due to the high advantage of micronutrients in preventive medicine and supplementary treatment of many diseases and on the other hand due to the fact that orthomolecular medicine has no side effects and due to thefact that an increasing number of patients is dissatisfied with conservative traditional medicine.

The effect of orthomolecular substances was proved in many large studies, particularly in English-speaking countries. In Germany, however, we still have little data available. Above all, long-term studies under practical conditions are missing, particularly on complex preparations for primary- and secondary prevention, which contain the most important micronutrients in a balanced relation and sufficient dosage.

There is a high backlog in scientifically usable information on large patient groups, which took these products for a longer time period.

As our non-profit association does not have the necessary organisational structures nor the necessary financial funds for establishment and evaluation of data, we have to find institutions that take over these tasks and the associated costs.

Therefore, we particularly appreciate that some producers and service suppliers in the nutritional medical field have provided us with comprehensive data material from the previous 5 years with emphasis on orthomolecular medicine in prevention and have kindly assumed the associated costs. Currently, we make efforts to find a partner who is able to assume logistics and costs for the evaluation of already existing and still incoming data.

Others

Publicity